Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Eye, Ear & Vision

Display color gamut as a spectral risk factor for myopia: a unifying hypothesis linking chromatic emmetropization, cone circuitry dysfunction, and the spectral deficiency of digital screens

The global prevalence of myopia in children rose from 24% in 1990 to 36% in 2023, with projections exceeding 39% by 2050.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors propose a hypothesis that the spectral power distribution of digital displays may be an environmental risk factor for myopia, because screens emit no measurable light below about 420 nm and their narrow-band primaries may distort the 490-560 nm region. The paper is a hypothesis article that draws on several lines of evidence rather than reporting new experimental results. The authors state the mechanism is not yet established and call for evaluation of display color gamut as a modifiable variable.

Who or what was studied
unclear
Wavelengths
420, 360, 400, 380, 490, 560 nm
Limits stated in the abstract
The abstract presents a hypothesis supported by converging lines of evidence, and the proposed mechanism has not been directly tested in the paper.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

The global prevalence of myopia in children rose from 24% in 1990 to 36% in 2023, with projections exceeding 39% by 2050. While time spent outdoors is robustly protective against myopia, the specific spectral properties of light responsible for this protection remain insufficiently characterized. We propose that the spectral power distribution (SPD) of modern digital displays may represent a previously unrecognized environmental risk factor for myopia through the systematic elimination of two wavelength bands critical to emmetropization. All current display technologies emit no measurable light below approximately 420 nm, entirely excluding the violet band (360-400 nm) that activates OPN5/neuropsin (λmax ≈ 380 nm) in retinal ganglion cells. Additionally, the narrow-band RGB primary architecture of displays distorts the cyan-green region (490-560 nm), potentially perturbing the SWS/LWS opponent chromatic signal that the Gawne-Norton dual-detector model identifies as the primary longitudinal chromatic aberration (LCA)-based drive for emmetropization. These two mechanisms are consistent with the dose-response relationship between screen time and myopia risk documented in large-scale epidemiological studies. The hypothesis is grounded in five converging lines of evidence: (1) the OPN5/violet light pathway; (2) the LCA dual-detector emmetropization model; (3) genetic evidence from Blue Cone Monochromacy and Bornholm Eye Disease; (4) red-light therapy trials; and (5) subgroup analyses by display device type. We propose that display color gamut - and the spectral power distribution it determines - currently optimized exclusively for colorimetric fidelity, merits evaluation as a modifiable variable in the global myopia control agenda.

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

Light parameters mentioned

Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.

Wavelength
420 nm, 360-400 nm, 380 nm, 490-560 nm

How to read a single study: what to check before relying on this kind of research.

Terms in this paper: Myopia, Dose-response relationship, Wavelength, Dose. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies